Diseases Current Affairs
World Diabetes Day was observed every year across the world on 14 November to raise awareness about diabetes. Observance of day aims to pursue multilateral efforts to promote and improve human health and provide access to health-care treatment and education.
The theme for World Diabetes Day 2018 and 2019 is “The Family and Diabetes”. The two-year theme timeframe has been chosen to aise awareness of the impact that diabetes has on the family and support network of those affected and promote role of family in management, care, prevention and education of diabetes.
The World Diabetes Day was instituted by United Nations General Assembly (UNGA) in 2007 by passing resolution A/RES/61/225. The resolution had encouraged Member States to develop national policies for prevention, treatment and care of diabetes.
Diabetes is a chronic, progressive non-communicable disease (NCD) characterized by elevated levels of blood sugar (blood glucose). It occurs when (i) the pancreas does not produce enough of the insulin hormone, which regulates blood sugar (ii) the body cannot effectively use the insulin it produces. Type 1 diabetes occurs when the body doesn’t make enough insulin, and type 2 diabetes occurs when the body doesn’t make or use insulin very well, causing glucose to remain in the blood, which can lead to serious problems. The main symptom of diabetes is excess fatigue, frequent urination, dysentery, excessive thirst, etc. Diabetes can also be genetic, but its main cause is obesity, lack of adequate nutrition, etc. Insulin injection is given to the patient suffering from type 1 diabetes. Prevention of type 2 diabetes is quite possible.
Indian Health Fund: 4 innovators selected for early detection of TB, malaria by Tata Trust and The Global Fund
Tata Trust and The Global Fund backed Indian Health Fund (IHF) has chosen four innovators for early detection of tuberculosis (TB), malaria to effectively tackle these eradicate diseases. Three selected innovators are related to TB and one to malaria. They were selected from proposals received for its second Request for Proposals.
The aim for selecting these innovators aims at leveraging technology for improving early detection and prompt treatment along with promoting diagnostics feasible for primary health care facilities. It also aims to supporting national efforts to effectively tackle eradicate these diseases which is crucial health challenges in India. Government has set a target of eliminating TB by 2025 and malaria by 2030. India contributes to 27% of the global TB burden and 68% of all malaria cases in the Southeast Asia region
Indian Health Fund (IHF)
IHF was launched in 2016 by Tata Trusts in collaboration with The Global Fund, to drive innovations towards key infectious disease challenges in India. It supports individuals and organisations with already germinated innovative strategies, services, products, such that they become sustainable and scalable solutions in addressing TB and malaria. The initiative is not a fellowship programme to do research from scratch. It is long-term exercise aligned with country’s goal of eliminating TB by 2025 and malaria by 2030. It will promote innovative solutions such that they are widely accessible and are affordable.